Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1 Head & Neck 1 Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 10 Colorectal Neoplasms 9 Rectal Neoplasms 8 Wilms Tumor 7 Pancreatic Neoplasms 7 Neuroblastoma 7 Lymphoma, Non-Hodgkin 7 Hepatoblastoma 7 Glioma 7 Sarcoma 6 Rhabdomyosarcoma 6 Rhabdoid Tumor 6 Osteosarcoma 6 Neuroectodermal Tumors, Primitive, Peripheral 6 Medulloblastoma 6 Histiocytosis, Langerhans-Cell 6 Ependymoma 6 Lung Neoplasms 5 Central Nervous System Neoplasms 5 Stomach Neoplasms 4 Sarcoma, Ewing 4 Ovarian Neoplasms 4 Esophageal Neoplasms 4 Colonic Neoplasms 4 Melanoma 3 Endometrial Neoplasms 3 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Lymphoma 2 Liver Neoplasms 2

Interventions

Gemcitabine 69 Fluorouracil 44 pembrolizumab 43 Oxaliplatin 42 Capecitabine 40 Bevacizumab 37 Leucovorin 36 Irinotecan 31 Cisplatin 27 Nivolumab 23 Paclitaxel 21 Cetuximab 21 Panitumumab 20 130-nm albumin-bound paclitaxel 20 Sorafenib 18 Albumin-Bound Paclitaxel 18 Drug Therapy 15 Docetaxel 15 Cyclophosphamide 15 Radiotherapy 14 Blood Specimen Collection 14 IFL protocol 12 Exercise 11 atezolizumab 10 Taxes 10 budigalimab 9 Erlotinib Hydrochloride 9 trametinib 8 Folfox protocol 8 Carboplatin 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × X-Rays × Gastrointestinal × Clear all

NCT02207959 2017-05-02

Gastric In Vivo Study

Icahn School of Medicine at Mount Sinai

Phase 1 Terminated

Gastrointestinal

Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡